507 related articles for article (PubMed ID: 10875231)
1. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
2. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC; Matzuk MM
Mol Endocrinol; 1999 Jun; 13(6):851-65. PubMed ID: 10379885
[TBL] [Abstract][Full Text] [Related]
3. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM
Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
[TBL] [Abstract][Full Text] [Related]
5. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
6. SMAD3 regulates gonadal tumorigenesis.
Li Q; Graff JM; O'Connor AE; Loveland KL; Matzuk MM
Mol Endocrinol; 2007 Oct; 21(10):2472-86. PubMed ID: 17595316
[TBL] [Abstract][Full Text] [Related]
7. Role of androgens in testicular tumor development in inhibin-deficient mice.
Shou W; Woodruff TK; Matzuk MM
Endocrinology; 1997 Nov; 138(11):5000-5. PubMed ID: 9348231
[TBL] [Abstract][Full Text] [Related]
8. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
9. Inhibin and p27 interact to regulate gonadal tumorigenesis.
Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
[TBL] [Abstract][Full Text] [Related]
10. Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.
Gold E; Marino FE; Harrison C; Makanji Y; Risbridger G
J Pathol; 2013 Mar; 229(4):599-607. PubMed ID: 23180294
[TBL] [Abstract][Full Text] [Related]
11. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
[TBL] [Abstract][Full Text] [Related]
12. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development.
Matzuk MM; Kumar TR; Shou W; Coerver KA; Lau AL; Behringer RR; Finegold MJ
Recent Prog Horm Res; 1996; 51():123-54; discussion 155-7. PubMed ID: 8701077
[TBL] [Abstract][Full Text] [Related]
13. Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice.
Rajanahally S; Agno JE; Nalam RL; Weinstein MB; Loveland KL; Matzuk MM; Li Q
Reprod Biol Endocrinol; 2010 Jun; 8():69. PubMed ID: 20565978
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of mouse follistatin causes reproductive defects in transgenic mice.
Guo Q; Kumar TR; Woodruff T; Hadsell LA; DeMayo FJ; Matzuk MM
Mol Endocrinol; 1998 Jan; 12(1):96-106. PubMed ID: 9440814
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice.
Kumar TR; Wang Y; Matzuk MM
Endocrinology; 1996 Oct; 137(10):4210-6. PubMed ID: 8828479
[TBL] [Abstract][Full Text] [Related]
16. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
Marino FE; Risbridger G; Gold E
Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
[TBL] [Abstract][Full Text] [Related]
17. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.
Roberts VJ; Barth S; el-Roeiy A; Yen SS
J Clin Endocrinol Metab; 1994 Nov; 79(5):1434-9. PubMed ID: 7962340
[TBL] [Abstract][Full Text] [Related]
18. Genetic engineering to study testicular tumorigenesis.
Yan W; Burns KH; Matzuk MM
APMIS; 2003 Jan; 111(1):174-81; discussion 182-3. PubMed ID: 12760377
[TBL] [Abstract][Full Text] [Related]
19. Inhibin subunit gene expression in ovarian cancer.
Fuller PJ; Chu S; Jobling T; Mamers P; Healy DL; Burger HG
Gynecol Oncol; 1999 May; 73(2):273-9. PubMed ID: 10329046
[TBL] [Abstract][Full Text] [Related]
20. Activins in reproductive biology and beyond.
Wijayarathna R; de Kretser DM
Hum Reprod Update; 2016 Apr; 22(3):342-57. PubMed ID: 26884470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
